NanoString Technologies
Developer of spatial biology tools for life sciences research, now part of Bruker Spatial Biology.
About
Technology stack
detected 2026-05-22
AWSNo comments yet. Be the first to share your take.
What does NanoString Technologies do?
NanoString Technologies was a biotechnology company focused on discovery and translational research, developing and marketing technologies for targeted detection of biological markers. Its platforms, including nCounter, GeoMx Digital Spatial Profiler, and CosMx Spatial Molecular Imager, enable scientists to explore gene expression and protein analysis in tissue samples. The company filed for Chapter 11 bankruptcy in February 2024 and its assets were acquired by Bruker Corporation in May 2024.
How much funding has NanoString Technologies raised?
NanoString Technologies has raised a total of $15M in funding. The most recent round on record is Series E.
Where is NanoString Technologies headquartered?
NanoString Technologies is headquartered in Seattle, United States.
When was NanoString Technologies founded?
NanoString Technologies was founded in 2003.
What industry does NanoString Technologies operate in?
NanoString Technologies operates in Biotechnology, Life Science Tools, Spatial Biology, Gene Expression Analysis, Molecular Diagnostics, Genomics.
How many employees does NanoString Technologies have?
NanoString Technologies has approximately 323 people on record.
What is NanoString Technologies's current status?
NanoString Technologies's current operating status is: Inactive.